Prescription medicine
Cobaltous and technetium tc 99m exametazime Brand names: Ceretec
Cobaltous and technetium tc 99m exametazime (Ceretec) is a prescription medicine. No generic is listed in FDA's NDC Directory.
- No generic listed
Check it at the source: the cobaltous and technetium tc 99m exametazime FDA label on DailyMed (effective January 10, 2024); every cobaltous and technetium tc 99m exametazime label on DailyMed.
Highlights of the record
FDA label of January 10, 2024; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageCeretec is a radioactive diagnostic agent, indicated in adults and pediatric patients age 2 to 17 for: Leukocyte Labeled Scintigraphy – As an adjunct in the localization of intraabdominal infection and inflammatory bowel disease.
Forms and strengths
Kit.
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 1 of which 0 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 37 through July 30, 2026
What is cobaltous and technetium tc 99m exametazime used for?
From the label: indications and usageCeretec is a radioactive diagnostic agent, indicated in adults and pediatric patients age 2 to 17 for: Leukocyte Labeled Scintigraphy – As an adjunct in the localization of intraabdominal infection and inflammatory bowel disease. ( 1.1 ) Cerebral Scintigraphy – As an adjunct in the detection of altered regional cerebral perfusion in stroke. […]
Source: FDA drug label (Ceretec), Medi-Physics, Inc. dba GE Healthcare, effective January 10, 2024 (SPL set d9c291e0-cd0d-43d2-87b4-defefd531942), via openFDA; the full label on DailyMed
Is there a generic for cobaltous and technetium tc 99m exametazime (Ceretec)?
No generic cobaltous and technetium tc 99m exametazime is approved (Drugs@FDA, October 8, 2026).
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What does the cobaltous and technetium tc 99m exametazime label say about other medicines?
The cobaltous and technetium tc 99m exametazime label names 1 other medicine in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Tetrakis copper tetrafluoroborate | warnings and precautions | Radiation Exposure Risk Technetium Tc 99m contributes to a patient's overall long-term cumulative radiation exposure, which is associated with an increased risk of cancer. |
Check cobaltous and technetium tc 99m exametazime against other medicines
Source: FDA drug label (Ceretec), Medi-Physics, Inc. dba GE Healthcare, effective January 10, 2024 (SPL set d9c291e0-cd0d-43d2-87b4-defefd531942), via openFDA; the full label on DailyMed
What do FAERS reports show for cobaltous and technetium tc 99m exametazime?
The FDA Adverse Event Reporting System holds 37 reports that list cobaltous and technetium tc 99m exametazime among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 3 are coded as a death and 3 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Cobaltous and technetium tc 99m exametazime side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other